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Abstract
Since the advent of genome-wide small interfering RNA screening, large numbers of cellular cofactors important for viral
infection have been discovered at a rapid pace, but the viral targets and the mechanism of action for many of these
cofactors remain undefined. One such cofactor is cyclophilin A (CyPA), upon which hepatitis C virus (HCV) replication
critically depends. Here we report a new genetic selection scheme that identified a major viral determinant of HCV’s
dependence on CyPA and susceptibility to cyclosporine A. We selected mutant viruses that were able to infect CyPA-
knockdown cells which were refractory to infection by wild-type HCV produced in cell culture. Five independent selections
revealed related mutations in a single dipeptide motif (D316 and Y317) located in a proline-rich region of NS5A domain II,
which has been implicated in CyPA binding. Engineering the mutations into wild-type HCV fully recapitulated the CyPA-
independent and CsA-resistant phenotype and four putative proline substrates of CyPA were mapped to the vicinity of the
DY motif. Circular dichroism analysis of wild-type and mutant NS5A peptides indicated that the D316E/Y317N mutations
(DEYN) induced a conformational change at a major CyPA-binding site. Furthermore, nuclear magnetic resonance
experiments suggested that NS5A with DEYN mutations adopts a more extended, functional conformation in the putative
CyPA substrate site in domain II. Finally, the importance of this major CsA-sensitivity determinant was confirmed in
additional genotypes (GT) other than GT 2a. This study describes a new genetic approach to identifying viral targets of
cellular cofactors and identifies a major regulator of HCV’s susceptibility to CsA and its derivatives that are currently in
clinical trials.
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Introduction
Successful completion of the life cycle of a virus depends not
only on the function of proteins encoded by the virus but also on
cellular cofactors. The availability of genome-scale small interfer-
ing RNA (siRNA) libraries and high-throughput screening
technology has permitted systematic efforts to discover cellular
proteins important for viral infections in cell-culture systems.
Typically, proteins with apparent functional relevance to the
particular virus are characterized in detail after the discovery, but
the mechanisms of action for many other cofactors remain
undefined. An important step toward the illustration of the
mechanism is to identify the viral agent through which a cofactor
functions. Although in rare cases, when small chemical com-
pounds are available whose target is the cellular cofactor,
screening for compound-resistant mutant virus can provide
valuable information about the viral target, but this approach is
not useful for the majority of cofactors. Here we report a new
genetics approach, which we designate cofactor-independent
mutant (CoFIM) screening, to identify the viral targets of cellular
cofactors through the selection of mutant viruses that can replicate
in cells where a particular cellular cofactor is knocked down.
Because our approach does not rely on prior knowledge of the
function of the cofactor or the availability of chemical inhibitors, it
may be broadly applicable to cellular cofactors with unknown
mechanisms of action.
Various cellular proteins have been implicated in the life cycle
of hepatitis C virus (HCV), identified mostly by protein-protein
interaction and/or siRNA library screening [1]. A critical role for
cyclophilins (CyPs) in HCV replication was first suggested by the
direct antiviral effect of cyclosporine A (CsA) [2,3]. We and others
then identified CyPA as the main CyP isoform that serves as an
essential cofactor for HCV infection [4,5,6] and the principal
mediator of CsA resistance [4,5]. In addition, the peptidyl-prolyl
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for HCV replication [5,6,7]. Although CyP inhibitors are
currently being studied in clinical trials as a novel class of anti-
HCV drugs, the viral target of CsA and the substrate of CyPA’s
PPIase activity are not well characterized. Nonstructural proteins
5B (NS5B), NS5A, and NS2 have all been proposed to be potential
targets of CyPA [8,9,10,11,12]. In addition, resistance-mapping
studies using subgenomic replicons have so far generated a
fragmented picture of determinants of CsA susceptibility [5,9,12].
In this study, we isolated a mutant JFH-1 full-length virus that
escaped the inhibition by shRNAs targeting CyPA. Characteriza-
tion of the mutant virus revealed a critical dipeptide motif and
several surrounding prolines in domain II of NS5A to be the
principal modulators of CyP dependence and CsA sensitivity, in a
cell culture model of HCV infection (HCVcc) [13,14,15,16].
Results
In vitro selection of a HCV mutant strain that is less
dependent on CyPA and less susceptible to CsA
Although CsA-resistant replicons have been isolated [5,9,12],
attempts to obtain CsA-resistant full-length HCVcc had been
unsuccessful. Because we previously observed a potent block of
HCVcc infection of Huh-7.5 cells expressing a small-hairpin RNA
(sh-A161) that downregulated CyPA expression by more than 90%
[4], we devised a CoFIM selection for CyPA using this shRNA to
obtain a HCV mutant that was less dependent on CyPA. In the
first selection, we infected Huh-7.5 cells with JFH-1 at a low
multiplicity of infection (MOI,0.01) and cultured the cells until
100% of the cells became positive for HCV staining. We reasoned
that the relatively long period (10–14 days) of infection spreading
time might maximize the diversity of the HCV quasispecies and
increase the number of preexisting mutations. We then transduced
into the infected Huh-7.5 cells a lentiviral vector expressing sh-
A161 (Figure 1A). After a 2-wk antibiotic selection of shRNA-
expressing cells, more than 95% of the cells cleared viral infection
as a result of suppression of CyPA, but a small percentage (,5%)
of cells remained positive for HCV core staining. Continued
culturing of these cells for one more week resulted in a population
of cells that were 100% infected despite efficient CyPA
knockdown, indicating the emergence of a mutant virus that
could replicate efficiently with significantly lower levels of CyPA.
Viral particles produced from these selected cells were collected
and then used to infect Huh-7.5 cells expressing shRNAs directed
at firefly luciferase (sh-Luc), CyPA (sh-A161), or CyPA and CyPB
(sh-Broad). Although wild-type (WT) JFH-1 could only infect the
sh-Luc cell line, the selected virus, designated J-LA, infected all
three cell lines with high efficiency (Figure 1B). These results
indicated that J-LA was less dependent on CyPA and did not
develop the ability to use CyPB as a substitute cyclophilin in the
presence of CyPA knockdown. We then measured the CsA
sensitivity of JFH-1 and J-LA and observed a greater than 16-fold
shift of CsA sensitivity (Figure 1C), consistent with our previous
finding that the CsA resistance was correlated with reduced
dependence on CyPA in the setting of a subgenomic replicon [4].
The reduced dependence on CyPA was specific, as J-LA virus was
not able to infect Huh-7.5 cells containing a shRNA targeting
either one of two other essential HCV cofactors (Phosphatidyli-
nositol 4-kinase alpha and Occludin-1) (Figure 1D)
[17,18,19,20,21,22,23,24,25].
Mutations in a dipeptide motif in domain II of NS5A are
responsible for the reduced dependence on CyPA and
the reduced susceptibility to CsA
Three additional independent CoFIM selections (#2, 3, 4 in
Table 1) with different parameters produced additional prepara-
tions of mutant viruses that were capable of infecting CyPA
knockdown cells. The order of HCV and shRNA introduction into
the cells was reversed in two of the experiments to reveal whether
the same mutant viruses can emerge with preexisting selection
pressure. Interestingly, the process took much longer (6 rather
than 3 wk) to produce sh-A161-resistant virus when JFH-1 RNA,
transcribed in vitro with T7 phage polymerase from a DNA
plasmid as template, was electroporated directly into sh-A161 cells,
probably because of the lack of diversity and preexisting mutations
in the input RNA. Sequence analysis of these mutant viruses
revealed related mutations in a dipeptide motif (D316 and Y317)
in the domain II of NS5A in all four mutant viral samples. In
addition, an I31T mutation in E2 was identified in three of the
four selections, whereas the remaining selection revealed a T33A
mutation, also in the E2 protein (Table 1). We engineered mutant
viruses containing either the E2 mutation I31T or the NS5A
mutations and tested their ability to infect sh-A161 cells. The
mutant virus containing E2:I31T was not able to infect sh-A161
cells efficiently, and further passage of this virus in sh-A161 cells
resulted in the emergence of the NS5A:Y317N or NS5A:Y317H
mutation (#5 in Table 1). These data suggested that the E2:I31T
mutation was not able to confer reduced dependence on CyPA,
consistent with a recent report that this mutation increased
infectivity of HCVcc by reducing lipoprotein association with viral
particles, a process not known to involve CyPA [26]. The NS5A
mutations, however, did confer reduced CyPA dependence on
WT virus when engineered into either the JFH-1 (Figure 2A) or
the J6-JFH background (Figure S1). Neither WT virus was able to
replicate in sh-A161 cells, but mutant viruses harboring D316E,
Y317N, or both mutations replicated efficiently in these cells.
While the single mutants replicated 5- to 10-fold less in sh-A161
cells than in sh-Luc cells, a combination of the two generated a
genome (DEYN) that replicated several fold more efficiently in sh-
A161 cells than in the control cells (Figure 2A). The same pattern
was observed when the viral genomes were introduced by means
of infection rather than electroporation of RNA: the DEYN virus,
produced from either sh-Luc or sh-A161 cells, infected sh-A161
Author Summary
Identification of cellular cofactors and their mechanisms of
action is a fundamental aspect of virus-host interaction
research. Screening of genome-wide small interfering RNA
libraries has become an efficient way of systematically
discovering cellular cofactors essential for various aspects
of viral life cycle. We and others have recently demon-
strated that cyclophilin A (CyPA) is an essential cofactor for
hepatitis C virus (HCV) infection and serves as the direct
target of a new class of clinical anti-HCV compounds,
cyclosporine A (CsA) and its derivatives, that are devoid of
immunosuppressive function. Here we report the identi-
fication of a key regulator of HCV’s dependence on CyPA
and susceptibility to CsA using a novel genetic screening
approach that can potentially be applied to additional
cellular cofactors and other viruses. The effectiveness of
this approach, termed cofactor-independent mutant (Co-
FIM) screening, was further supported by results obtained
with a parallel CsA-based selection using additional
genotypes of HCV. This paper reports a new technology
with which we discover and characterize the major
determinant of HCV’s sensitivity to CyPA inhibitors, which
are currently being tested in clinical trials.
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single mutants again had an intermediate phenotype (Figure 2B).
Of note, approximately same amount of viruses were produced by
WT and the mutant genomes in sh-Luc cells (Figure 2C),
indicating that these mutations do not significantly impact viral
assembly. Furthermore, sh-A161 cells replicating DEYN mutant
RNA showed no defect in producing viral particles (Figure 2C,
stripe bar) that were able to infect naı ¨ve sh-A161 cells (Figure 2B,
stripe bar), suggesting that the DEYN virus is capable of
completing the entire viral life cycle efficiently in this CyPA
knockdown environment. In addition, other selected mutations
(Y317H, Y317R) at the Y317 position also conferred reduced
CyPA dependence on the J6-JFH virus (Figure S1). Finally, the
double mutant (DEYN) exhibited an approximately 20-fold
resistance to CsA treatment but remained sensitive to IFN
treatment (Figure 2D, Figure S2). Together, these data identify
NS5A as a major viral target of CyPA and demonstrate that the
DY motif in NS5A is a major determinant for CyPA dependence
and CsA susceptibility.
A near-perfect repeat of the peptide containing the DY motif
and the four prolines occurs immediately downstream in the JFH-
1 NS5A protein (Figure S3A), but we did not recover any
mutations in this second DY motif in any of our screens.
Moreover, mutation of this second DY motif (D329EY330N)
resulted in a replication-deficient virus (Figure S3B). These data
suggest a functional divergence of the two repeated DY motifs.
Mapping the putative proline substrates of CyPA
Several independent studies recently demonstrated that the
PPIase motif of CyPA is essential for HCV replication [5,6,7],
Figure 1. CoFIM selection of a full-length HCV that is less dependent on CyPA. (A) A diagram of CoFIM selection #1. Sh-A161 was
introduced into infected cells and selected with puromycin. Stable cells were then passaged until all cells became infected. (B) The selected mutant
virus (J-LA) efficiently infects CyPA and CyPB knockdown cells. Supernatant collected from (A) was used to infect cells harboring indicated shRNAs;
infected cell lysates were collected 4 days after infection and analyzed by SDS-PAGE and western blotting. A cellular protein, Ku80, was detected as a
loading control. (C) J-LA is more resistant to CsA treatment than WT JFH-1. Huh-7.5 sh-Luc cells were infected with JFH-1 or J-LA for 24 h before CsA
was added to the culture medium. The cells were incubated for 4 more days before being lysed and analyzed for NS3 expression. (D) J-LA virus
efficiently infects CyPA knockdown cells but not PI4K or Occludin knockdown cells. Equal numbers of Huh-7.5 cells harboring either control or the
indicated shRNAs were seeded and infected with either JFH-1 or J-LA virus. Five days after infection, cells were fixed and subjected to anti-NS3
antibody staining. Data shown in (B), (C), and (D) represent two independent experiments.
doi:10.1371/journal.ppat.1001118.g001
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substrates for CyPA. We reasoned that the DY motif, which
locates to a major CyPA-binding peptide in this domain [11] but
not proline themselves, probably confer CsA resistance through
the proline substrates of CyPA, and that consequently the
mutation of the relevant prolines would affect DEYN’s ability to
replicate in CyPA knockdown cells. To identify such proline
residues, we changed the individual prolines (14 total, Figure 3A)
in the domain II of NS5A into alanines, both in the WT and the
DEYN background of the J6-JFH genome (Table 2). The mutant
genomes were then electroporated into both sh-Luc and sh-A161
cells for measurement of replication capacity. The replication
phenotypes of these mutants fell into three categories. Mutations of
the first group of prolines had no effect on either the WT’s or the
DEYN’s ability to replicate in both cell lines; i.e., a proline mutant
in the WT background would replicate in sh-Luc cells but not in
sh-A161 cells, whereas the same proline mutant in the DEYN
background would replicate in both cells with high efficiency
(Figure 3B). Mutations of the second group of prolines had
minimal effect on the WT virus but reversed the replication
capacity of the DEYN virus in sh-Luc and sh-A161 cells
(Figure 3C); i.e., the DEYN + proline mutant replicated less
efficiently in sh-A161 cells than in the control cells. Mutation in
the third group, which included only one proline (P310), had the
most profound effect: P310A reduced the replication capacity of
the WT virus to the level of the GND pol- virus in both cells
(Figure 3D left panel, 3E), it also completely abolished DEYN’s
ability to replicate in sh-A161 cells (Figure 3D, right panel);
moreover, it reduced the replication capacity of DEYN virus in the
control cells more than any other single proline mutant (Figure 3D,
right panel). These data suggested a functional interaction between
the DY motif and the four prolines in groups II (prolines 315, 319,
320) and III (proline 310) in determining CyP dependence and
CsA susceptibility, and a possible use by CyPA of multiple prolines
as substrates on the NS5A protein. The importance of prolines 310
and 315 in HCV replication was further supported by results from
double and quadruple mutants in the DEYN background. DEYN
was not able to rescue the replication of either the quadruple
mutant (with all 4 prolines mutated to alanine) or a double mutant
containing P315A and P310A (Figure 3F).
DEYN mutations do not affect CyPA-binding or NS5A-
NS5B cleavage
To determine whether the DEYN mutations affect the CsA
sensitivity of NS5A’s binding to CyPA, we first established a
biochemical binding assay for the CyPA-NS5A interaction.
Recombinant forms of WT and three mutant CyPA proteins that
each contained a single mutation in the active site of the PPIase
(Figure 4A) [27] were purified as hexahistidine-tagged proteins
and mixed with lysates of JFH-1 infected cells for an affinity pull-
down experiment. WT CyPA efficiently bound to full-length
NS5A in this assay. The F113A mutant retained approximately
10–20% of NS5A-binding, while mutations R55A and F60A
completely abolished NS5A-binding by CyPA (Figure 4B). These
results demonstrated the importance of CyPA’s PPIase motif in
NS5A-binding. We next added increasing amounts of CsA to the
binding reaction and observed that the CyPA-NS5A interaction is
sensitive to CsA. However, DEYN mutations did not significantly
alter the CsA-sensitivity of this interaction (Figure 4C). These data
argue against the possibility that the DEYN mutations conferred
CsA resistance to the virus by altering CyPA-NS5A binding. We
also analyzed the possible connection between CyPA-indepen-
dence and the phosphorylation status of NS5A. In the biochemical
binding assay, the CyPA interacted with both forms (hyper- and
basal-phosphorylated) of NS5A to approximately the same extent
(Figure S4A). In addition, neither DEYN mutations nor CsA
treatment changed the relative ratio of these two phosphorylated
forms (Figure S4B). We conclude from these experiments that
CyPA’s action is probably unrelated to the phosphorylation status
of NS5A. We next determined whether the CsA resistance
conferred by these mutations was related to altered cleavage
kinetics at the NS5A-NS5B junction, as suggested by a previous
study [5]. The DEYN mutations in JFH-1 were transferred into a
polyprotein expression plasmid, which was then used to express
HCV proteins for the measurement of cleavage kinetics. These
mutations produced no significant effect on the rate of NS5A-
NS5B cleavage (Figure 4D), suggesting that the DEYN mutant
identified here uses a mechanism distinct from those of the
previously reported cleavage mutants (NS5A:V464A;
NS5A:V464L) that could also replicate, albeit to a lower level,
in a CyPA-knockdown cell line [5].
DEYN mutations confer a conformational change at a
major CyPA substrate site on the NS5A protein
The domain II of NS5A has been shown to be largely
disordered [28]. We first determined whether this domain, which
contains the DEYN mutations and the putative proline substrates,
had the potential to adopt different structural conformation.
Circular dichroism analysis of recombinant NS5A D2 resulted in
spectra indicative of a largely unordered structure (Figure 5).
When CD melting experiments were performed, however, an
isodichroic point between 209 nm –211 nm was observed in both
Table 1. Mutations identified in JFH-1 full-length viruses
a that are less dependent on CyPA for infection.
CoFIM Sel. Approach Time Mutations
E2 NS5A
1 CyPA KD in JFH-1–infected cells 3 wk I31T D316E
b Y317N, D316E+Y317N
2 CyPA + CyPB KD in JFH-1–infected cells 3 wk I31T D316E
b Y317N, D316E+Y317N
c
3 Electroporation of JFH-1 RNA into CyPA KD cells 6 wk T33A Y317H, Y317R
4 Infection of CyPA KD cells with JFH-1 3 wk I31T Y317N
5 Infection of CyPA KD cells with JFH-1 harboring E2:I31T mutation 3 wk I31T
d Y317N, Y317H
aHCV sequences were obtained from intracellular viral RNA.
bTwo types of nucleotide mutations (GAC R GAA; GAC R GAG) were found for the D316E mutation.
cOut of 19 bacterial clones sequenced from this selection, 9 contained D316E, 7 contained Y317N, and 3 contained D316E + Y317N.
dPreexisting E2 mutation.
doi:10.1371/journal.ppat.1001118.t001
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PLoS Pathogens | www.plospathogens.org 4 September 2010 | Volume 6 | Issue 9 | e1001118Figure 2. Mutations in a dipeptide motif in NS5A domain II confer CsA resistance and reduced CyPA-dependence. (A) Efficient
replication of mutant HCV genomes in CyPA knockdown cells. JFH-1 RNA harboring D316E, Y317N, or both was introduced into Huh-7.5 sh-Luc and
sh-A161 cells. Total RNAs were extracted 7, 48, 96, and 168 h after electroporation and subjected to quantitative RT-PCR for measurement of HCV and
GAPDH RNA. All the data were normalized to the 7 h input. (B) Infection of sh-A161 cells with mutant viruses. Infectious viral particles were collected
from transfected cells 48–72 hours after transfection and used to infect both sh-Luc and sh-A161 cells. The efficiency of infecting sh-A161 cells was
Co-FIM Selection and CyPA-Dependence of HCV
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of at least two different structural conformers in this domain for
both proteins. The CD spectra of WT and DEYN mutant
proteins, however, were very similar in these melting experiments,
indicating that there is no gross structural difference between WT
and mutant D2 proteins at the resolution of CD analysis. We then
analyzed a 20-mer peptide that contained the DY motif and the
four relevant prolines (G304-E323) (Figure 5C) to detect any
difference in local conformation introduced by the mutations at
this putative CyPA substrate site. Indeed, the spectral amplitude
corresponding to the DEYN mutant was more negative and
shifted to longer wavelengths compared to the WT peptide
(Figure 5C), indicating that the DEYN peptide may adopt a more
extended structure with less turn characteristics relative to the WT
peptide. To pinpoint the amino acid residues contributing to this
structural difference, we characterized each peptide using two
dimensional NMR spectroscopy. Specifically, we used 2D NOESY
spectra, in which cross peaks arise between protons that are close
in space (generally ,5A ˚). It is well known that helical or turn and
b-strand or extended conformations in peptides yield distinct NOE
patterns based on
1H-
1H distances in these secondary structures.
While the WT peptide adopts a mostly random coil structure,
NOE data clearly indicated a more extended structure between
residues 316 and 318 for the DEYN peptide. Specifically, we
observed sequential aN and NN NOEs for each non-proline
residue in the WT peptide, indicating that this peptide adopts a
conformational ensemble containing both extended and turn-like
conformations (Figure 6A). Interestingly, the amide resonances of
residues A311 and W312 exhibited large up-field shifts for a small,
random-coil peptide, consistent with the unusual resonance shifts
of the A311 and W312 residues observed in a full-length D2
construct [11], suggesting that the peptide may adopt similar
conformations as the NS5A protein. We observed sequential aN
NOEs for each non-proline residue in DEYN and sequential NN
NOEs between residues A311-R314 but did not see sequential NN
NOEs between E316-N318 (Figure 6B). This suggests that the DE
and YN substitutions bias the peptides towards more extended, b-
strand-like conformations compared to the WT sequence.
We also determined if CyPA acted on these peptide substrates
differently because of the structural difference that we observed.
Adding either the WT or the DEYN peptide to
15N-labeled CyPA
significantly perturbed the chemical shifts for the residues in the
same regions of CyPA (Figure S5) indicating that these two
peptides bound to the same region of CyPA, consistent with
equivalent binding in the biochemical binding assay. Adding a
catalytic amount of CyPA (,1:10) to the peptides caused chemical
shifts in the following residues: W312, A313, D/E316,Y/N317,
E323 (Figure 6, top). With the exception of E323, the peptide
residues that shifted upon addition of CyPA were all located
between P310 and P320, further supporting the notion that the
segment containing these four prolines is a major CyPA substrate
relevant for HCV replication. Moreover, we observed a sequential
NN NOE between D316-Y317 in WT peptide with or without
CyPA, indicating the presence of a turn formation between these
residues that is not dependent upon CyPA (Figure 6A, bottom). In
contrast, NOE analysis of DEYN peptide showed the absence of
an E316-N317 NN NOE, suggesting a reduced tendency for turn
formation in the absence of CyPA. Adding a catalytic amount of
CyPA to the DEYN peptide induced the formation of a similar
turn between residues E316-N317 as evidenced by the presence of
an E316-N317 NN NOE (Figure 6B, bottom). These data further
validate the DY motif as a major modulator of CyPA’s action.
The major CsA sensitivity determinant is conserved in
other genotypes and isolates
The putative peptide substrate of CyPA, centered around the
DY motif, is the most conserved region in NS5A domain II of GT
1a, 1b, and 2a (Figure 7A). To determine whether this major
determinant of CsA sensitivity that we identified in GT 2a is
functionally conserved across genotypes, we conducted a CsA-
resistance selection in a GT 1a replicon. Using a GT 1a replicon
labeled with red fluorescent protein (RFP), we isolated resistant
cells with high replication levels in the presence of CsA, a NS5B
inhibitor (200 nM of HCV-796), or an equivalent volume of
solvent (DMSO) (Figure 7B). The sensitivity of the selected cells to
three antiviral molecules, the protease inhibitor BILN-2061,
HCV-796, and CsA, was measured (Figure 7C). All cell lines
were equally sensitive to BILN-2061 and those selected in HCV-
796 were 74-fold less sensitive to HCV-796 but remained as
sensitive to CsA. In contrast, the replicon cells selected in the
presence of CsA exhibited specific resistance to CsA, and the levels
of resistance directly tracked the concentration of the compound
applied during selection.
The CsA-resistant replicon was also cross resistant to CsD, a
CsA derivative that is a potent inhibitor of CyPA with dramatically
reduced calcineurin binding [29], indicating that the resistant
replicon overcame CyPA inhibition rather than calcineurin
recruitment (Figure 7D). To determine the source of CsA
resistance, we tested the CsA sensitivity of a naı ¨ve GT 1b replicon
in the CsA-resistant cells. A WT 1b replicon with a Renilla
luciferase reporter was transfected into the GT 1a replicon cells
selected at 3 mM CsA. The sensitivity of the 1b replicon to CsA is
determined by monitoring of the luciferase signal. The 1b-
luciferase replicon was equally sensitive to CsA in WT or CsA-
resistant 1a-RFP replicon cells (Figure 7E). This result demon-
strated that the CsA resistance was driven by mutations in the
replicon and not in the host cell.
A D320E mutation, which is the equivalent of the D316E
mutation in JFH-1, was observed in CsA-resistant cell lines
selected with both 2 mM (50% of the bacterial clones sequenced
had the mutation) and 3 mM CsA (100% of the bacterial clones
sequenced had the mutation) but not in the control cell lines.
When the D320E mutation was engineered into a WT GT 1a
replicon, it conferred a statistically significant 2.7-fold shift in EC50
of CsA but no shift in the EC50 of the control antiviral compound
29CmeA (Figure 7F). In addition, the D320E 1a replicon was able
to replicate in sh-A161 cells, albeit to a lower level than in the
control cells, while the WT 1a replicon could not (Figure 7G).
Replication in control cells was not affected by the DE mutation.
We next determined whether the DEYN mutations could also
increase CsA resistance in the GT 1b background. We have
measured as the ratio of infectivity in sh-A161 cells to that in sh-Luc cells for each virus. For the virus harboring D316E/Y317N (DEYN) mutations,
particles produced from both sh-Luc (white bars) and sh-A161 (hatched bars) were tested. (C) The DE and YN mutations do not significantly impact
viral production. Huh-7.5 sh-Luc or sh-A161 cells were electroporated with indicated RNAs. At 72 hours post electroporation, cells were lysed for
intracellular luciferase activity and culture media were collected for core ELISA. (D) DEYN mutations confer CsA resistance on the J6-JFH genome.
Huh-7.5 sh-Luc cells were infected with WT J6-JFH (p7-Rluc2A) or DEYN/J6-JFH (p7-Rluc2A) for 24 h before CsA was added to the culture media. The
cells were incubated for 4 more days before being lysed and analyzed for luciferase expression. Error bars in (A), (B), (C), and (D) represent standard
derivations of at least two independent experiments.
doi:10.1371/journal.ppat.1001118.g002
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GT 1b replicon (NS5B:I432V) could confer a low level (1.5 fold) of
CsA resistance [9]. Combining DEYN with the NS5B mutation
generated a mutant replicon (DEYNI432V/Con1) that was
significantly more resistant (.4 fold) (Figure 8A). In addition, either
DEYN alone or DEYN combined with NS5B:I432V conferred the
abilityoftheCon1replicon toefficientlyreplicateinsh-A161cellsin
a colony-formation assay (Figure 8B). These data, together with
recent reports of the D320E mutation in CsA-resistant GT 1b
replicons [30,31], strongly suggest that the DY motif represents
key residues in a functionally conserved determinant of CyPA-
dependence and CsA susceptibility across genotypes.
Discussion
Using a newly developed genetic-selection approach, we
obtained for the first time a full-length, CsA-resistant HCV
genome that can replicate more efficiently in CyPA-knockdown
cells than in control cells. We also identified a specific dipeptide
motif that is a major controller of CyPA dependence and CsA
susceptibility. Mutation of this DY motif not only renders HCVcc
less dependent on CyPA and less sensitive to CsA treatment but
also changes the conformation of the NS5A peptide that binds to
CyPA. In addition, four prolines that represent putative substrates
of CyPA were mapped to a contiguous peptide surrounding the
DY motif with the most critical proline located six amino acids
upstream of the aspartic acid residue.
Increased RNA binding by HCV replicase and delayed NS5A-
NS5B cleavage have been proposed as potential mechanisms of
CsA resistance [5,30], correlated with reduced dependence on
CyPA [4]. The mechanism of the DEYN mutations, however,
appears to be distinct from either of these, as no difference was
observed in either CyPA binding or NS5A-NS5B cleavage. The
functional mapping and biophysical characterization of the
putative CyPA substrate on NS5A D2 suggests the following
molecular mechanism for DEYN-conferred CsA-resistance and
reduced CyPA dependence: The WT NS5A D2 structure is largely
disordered, containing a mixture of turn-like and more extended
conformations at the CyPA substrate site. Cis Xaa-Pro peptide
bonds further reduce the population of extended conformers in
this region. CyPA catalyzes cis-trans peptide bond interconversion
in NS5A, affecting the population of turn and extended
conformers. We propose that the latter are required for the
normal biological function of NS5A as part of a replicase
component. DEYN mutations cause the structural shift toward
this more extended form, reducing the dependence on CyPA to
induce such a structure. Of note, aspartate, present in the WT
sequence, is a strong N-capping residue for helix formation and
mutation to glutamate reduces the helical propensity for these
residues, increasing the population of structure conformers with
less turn features in the DEYN mutant compared to the WT. It is
interesting that CyPA introduces turn formations in the DEYN
peptide, presumably through mass action due to the larger
population of the extended conformers in this mutant.
The DEYN mutations confer the most marked CyPA-independent
phenotype reported thus far and do so in a full-length virus with all
viral proteins present. NS2 has recently been shown to increase CsA
sensitivity in either the full-length or a replicon background [5,10]. We
did not identify any mutations in the NS2 region in our screens, and
the DEYN mutation conferred resistance both in the presence (full-
length) or the absence (NS3-NS5B subgenomic replicon, Figure S6) of
NS2. In addition, the resistance-conferring mutations that we
previously identified in NS5B of a GT 1b replicon [9] were not
required for DEYN to confer reduced dependence on CyPA,
suggesting that the NS5A DY motif is the primary regulator of CyPA
dependence and CsA susceptibility. Note that residual amounts of
CyPA exist in Huh-7.5 sh-A161 cells [4], and the DEYN mutant virus
is inhibited by CsA at high concentrations (.8 mg/ml), suggesting that
either the remaining CyPA or other minor contributors to CsA
sensitivity such as other CyP isoforms expressed at low levels [4,32]
facilitate the replication of the DEYN virus in sh-A161 cells. Of note,
sh-A161 only inhibits the expression of CyPA, but not other CyP
isoforms (Figure S7). To address definitively the issue of CyPA
independence, a CyPA-knockout cell line similar to the one generated
by Braaten et al. [33] that is also susceptible to HCV infection may be
necessary. In this regard, we propose to apply the CoFIM designation
to viral mutants with either complete independence or reduced
dependence on cellular cofactors.
Figure 3. Putative proline substrates of CyPA in NS5A domain II. (A) Sequence of NS5A domain II. Each proline was changed to alanine in
both WT and the DEYN background, using the J6-JFH genome. Mutant RNAs were electroporated into both Huh-7.5 sh-Luc and sh-A161 cell lines,
and luciferase assays were performed at the indicated time points. The prolines were grouped into three categories according to phenotype.
Representative replication kinetics of the mutants are shown in (B) for group I, (C) for group II and (D) for group III. The replication profiles of a GND
replication defective mutant is shown in (E). (F) DEYN mutations fail to alleviate the lethal phenotype of double (P310AP315A) or quadruple prolines
mutants. Error bars in (B), (C), (D), (E), and (F) represent standard derivations of two to three independent experiments.
doi:10.1371/journal.ppat.1001118.g003
Table 2. Alanine-scanning mutagenesis of proline residues in
NS5A domain II.
Proline
mutation Replication capacity
a
WT D316E/Y317N mutations
sh-Luc sh-A161 sh-Luc sh-A161 sh-A161/sh-Luc
b
None +++ – +++ ++++ 1.7160.19
P270A n.d. n.d. ++ +++ 1.4560.01
P275A ++ – ++ +++ 1.8360.07
P282A ++ – ++ 1.5160.5
P292A ++ – +++ ++++ 1.3460.1
P295A ++ – ++ ++++ 2.1360.03
P301A ++++ – ++ ++++ 2.1460.01
P306A +++ – ++ +++ 1.1960.22
P310A – – + – 0.0160.00
P315A + – ++++ – 0.0460.01
P319A +++ – ++++ + 0.0460.01
P320A ++++ – ++++ +++ 0.5760.06
P328A + – ++ + 1.4560.2
P332A + – ++ +++ 1.3260.49
P333A n.d. n.d. ++ + 1.4260.02
aReplication capacity of the WT (fold increase from 4 h to day 3) was set at
100%, and the following scales were used: –, 0–10%; +, 11–50%; ++, 51–75%;
+++, 76–100%; ++++, .100%.
bThe ratio of replication capacity in sh-A161 cells to that in sh-Luc cells was
calculated and presented for all the D316E/Y317N mutation–based genomes.
Standard errors of two independent experiments are shown.
doi:10.1371/journal.ppat.1001118.t002
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replication have been identified previously, both in GT1b [34]
and GT2a [35]. In a cell-culture adapted GT1b replicon, two
prolines (P314 and P324) in domain II that are equivalent to P310
and P320 identified in this study were found to be critical for
colony formation of the replicon. In addition, several residues in
close proximity to these prolines were also essential for replication
[34]. It would be interesting to determine whether mutation of
these residues can influence CyPA-binding or the related
conformation change of NS5A. Finally, a polyproline motif
(PP2.1) that locates to the low-complexity sequence [36] between
domains II and III of NS5A can regulate both RNA replication
and viral assembly [35], raising the possibility of additional CyPA
substrates outside NS5A domain II. We speculate that the
isomerization of one or more of these prolines of NS5A by CyPA
is required for the proper function of NS5A, which is currently not
understood, in the life cycle of HCV.
CsA sensitivity appears to vary in different genotypes [37,38].
An independent selection with a GT 1a replicon identified D320E,
which is equivalent to D316E in JFH-1, as an important
Figure 4. DEYN mutations do not affect NS5A binding or NS5A-5B cleavage. (A) Structure of CyPA. Left panel: Space-fill model of CyPA-CsA
complex (2RMA) [52]. White: CyPA; orange: CsA. Right panel: residues in the active site of CyPA that are mutated in this study. Red: R55; blue: F60;
green: F113. (B) In vitro binding of CyPA to full-length NS5A. His-tagged CyPA proteins was incubated with infected cell lysate and then subjected to
Ni-NTA column pull-down. CyPA-NS5A complexes were eluted with Imidazole (bound) and then subjected to immunobloting with anti-NS5A
antibodies. Result shown is representative of two independent experiments. (C) WT and DEYN mutant NS5A protein exhibit similar CsA sensitivity in
NS5A binding. Binding reactions were performed as described in (B) with increasing amount of CsA present. (D) Cleavage kinetics at NS5A-5B site,
depicted by pulse-chase labeling and immunoprecipitation. NS5AB protein bands were quantified by densitometry, and we calculated viral protein
synthesis by dividing the values obtained for the chase samples by the corresponding values obtained from the 0 h chase samples. Molecular
weights are shown at the right; lines point to the respective HCV proteins.
doi:10.1371/journal.ppat.1001118.g004
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PLoS Pathogens | www.plospathogens.org 9 September 2010 | Volume 6 | Issue 9 | e1001118Figure 5. Circular Dichroism analysis of WT and DEYN NS5A D2 and peptides. (A) Thermal unfolding of wt NS5A D2 reveals an isodichroic
point at approximately 208 nm indicative of a b-turn/extended structure conformational transition [53,54]. Solid lines represent spectra collected
with increasing temperature (UP), with dashed lines showing reversibility of the unfolding process upon subsequent cooling of the wt NS5A D2
sample (DN). (B) Similar results were obtained for DEYN NS5A D2. (C) The circular dichroism spectra of the WT and DEYN mutant peptides exhibit
features characteristic of largely unfolded conformations. The difference in spectral magnitude and a slight shift in the position of the spectral
minimum, however, indicate a conformational difference between the WT and DEYN peptides. Result shown is representative of five independent
experiments.
doi:10.1371/journal.ppat.1001118.g005
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obtained with GT 1b replicons whereby the proline residues
surrounding the D320 residue are also important for replication of
the 1b genotype [30,31,34]. Analysis of the HCV sequences
deposited at the European HCV Database (euHCVdb) revealed
that the frequency of changes at both the DY motif and the four
prolines in natural isolates are low (Table 3). The most variable
position is NS5A 316 and its equivalent position, which had
substitutions in only 22 out of 2764 isolates. And although there
are some isolates that harbor either the D to E or the Y to N
change at the NS5A DY motif, we did not find a single natural
isolate that contains both changes. To further address the in vivo
relevance of the DY motif, it would be important to determine
whether mutations at this site can emerge from patients in clinical
trials treated with CsA derivatives such as DEBIO-025, NIM811,
or SCY-635 [39,40,41].
So far as we know, this is the first report of an shRNA-based
selection of viral mutants with reduced dependence on a cellular
cofactor. The general steps of Co-FIM selection starts with the
identification of a cellular cofactor, suppression of which would
lead to viral inhibition. The next step would be the selection of
viral variants that can replicate in the constant pressure of shRNA-
mediated knockdown of the cofactor. This can be done either by
introducing viral particles or genomes into stable knockdown cells
(selection # 3, 4, and 5) or transducing infected cells with lentiviral
vectors expressing shRNAs (selection #1 and 2). Sequencing and
identification of mutations in the selected viruses are then followed
by standard reverse genetics approaches to verify the effect of the
mutations. Obviously, a cellular cofactor that is also essential for
cell survival would not be amenable for this selection. Also, it
might be very difficult for a virus to bypass entire cellular pathways
that are important for its replication. For HCV, these may include
membrane-reorganizing factors and proteins involved in lipid
metabolism, to name a few.
In addition to target identification, the CoFIM screen may also
reveal novel cellular pathways involved in the viral life cycle and
identify cofactor hierarchy. For example, cross-resistance to
knockdown of multiple cofactors may place distinct factors in
the same pathway for viral infection and reveal previously
unidentified interactions. The strong agreement of our shRNA-
based results with those from independent compound-based
selection indicates that CoFIM screening may be applicable to a
Figure 6. CyPA induces turn conformations in DEYN. Superposition of 400 ms NOESY spectra of (A)W To r( B) DEYN peptide in the absence
(black) and presence (red) of CyPA at a 10:1 peptide:protein ratio. HN-Ha (top) and HN-HN (bottom) correlations are shown for each sample. WT
peptide exhibited sequential HN-Ha and HN-HN NOEs, indicating random coil ensemble of conformers. Addition of CyPA resulted in chemical shift
changes but did not significantly alter the NOE pattern or intensities. In contrast, DEYN peptide lacked sequential HN-HN NOEs in D316-N318 in the
absence of CyPA, indicating that the EN substitutions increased the population of extended conformers in this region relative to the WT peptide.
Addition of CyPA also resulted in chemical shift changes in DEYN peptide and introduced a sequential HN-HN NOE between E316-N317 that is not
seen in WT even at the lowest possible contour levels.
doi:10.1371/journal.ppat.1001118.g006
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PLoS Pathogens | www.plospathogens.org 11 September 2010 | Volume 6 | Issue 9 | e1001118Figure 7. Critical role of NS5A aspartate 316/320 in CsA activity extends to GT 1a. (A) Alignment of NS5A domain II sequences from Con1
(GT 1b), H77 (GT 1a), and JFH-1 (GT 2a). (B) A diagram of selection of CsA-resistant HCV genotype 1a replicon. Genotype 1a replicon cells were
selected by serial passaging in the presence of a selectable marker and either the specified antiviral or a comparable volume of solvent. (C) Specific
resistance by the selected cells to the selection drug used. The degree to which the EC50 of CsA was shifted corresponded to the concentration of CsA
in which the cells were selected. The EC50 of the nonnucleoside NS5B inhibitor HCV-796 is only shifted for the cells selected in HCV-796. (D) Replicon
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inhibitors or knowledge of mechanism.
Materials and Methods
Cell lines, replicons, viruses, antibodies, and compounds
Huh-7.5 cells and J6-JFH (p7-RLuc) were provided by Charles
M. Rice. JFH-1 constructs were provided by Takaji Wakita. Huh-
7.5 sh-Luc, sh-A161, and Huh-7-Lunet/T7 cells have been
described previously [4,5]. The genotype 1b–PI-luc replicon, used
for the supertransfection experiment, and genotype 1a replicons
have been described previously [42]. Monoclonal antibodies
against JFH-1 NS3 and NS5A were made in house. Compounds
BILN-2061 and 29CmeA were purchased from Acme Biosciences
(Palo Alto, CA), HCV-796 from Curragh Chemistries (Cleveland,
OH), IFN-a from Sigma-Aldrich (St. Louis, MO), and CsD from
Enzo Life Sciences International, (Plymouth Meeting, PA).
CoFIM selection of sh-A161 resistant JFH-1 virus:
transduction route
Huh-7.5 cells were infected with JFH-1 virus at MOI of ,0.01
for 4 h. The input virus was removed, and the cells were cultured
for 10–14 days, during which a small sample was removed every 3
days for immunofluorescence staining for HCV core and NS3
until all cells were positive for HCV. The infected cells were then
transduced with lentiviral vector sh-A161 and were selected in the
presence of 1.2 mg/ml puromycin for 3 wk. We first examined the
stable cells for CyPA/CyPB with western blotting to confirm
knockdown and then examined them for presence of HCV-
positive cells by NS3-staining. The cells were then cultured for
another week, during which a small sample was removed by every
2 days for determination of the percentage of infected cells.
Supernatant containing mutant viruses was collected once all the
cells again became 100% infected.
CoFIM selection of sh-A161 resistant JFH-1 virus:
infection/electroporation route
Huh-7.5 cells stably expressing sh-A161 were challenged with
JFH-1 viral particles or genome RNA transcribed in vitro. The
cells were then cultured for 3–6 wk, during which a small sample
was removed every 3 days for NS3 staining. Supernatant
containing mutant viruses was collected once .90% of the cells
became positive for HCV NS3.
Selection of CsA-resistant genotype 1a replicon
After 40 days of serial passaging in media supplemented with
increasing concentrations of CsA, cells fluorescing in the top 15%
of the population were isolated by flow cytometry. After outgrowth
in the high concentration of CsA, RNA isolation, RT-PCR, and
sequencing were performed by Tacgen (Hayward, CA). To
determine drug sensitivity, we seeded stable replicon cells in 96-
well plates at a density of 5610
3 cells per well or transiently
transfected replicon cells at 1.3610
4 cells per well and treated
them with compounds for 3 days, after which the cells were
assayed for luciferase or NS3 activity [43]. Activity levels were
converted into percentages relative to the untreated controls
(defined as 100%) and data were fit to the logistic dose response
equation y (a/(1+(x/b)c) with XLFit4 software (IDBS, Emeryville,
CA).
In vitro binding of CyPA and NS5A
Binding of recombinant His-CyPA to NS5A was performed
using total lysate collected from Huh 7.5 L-Luc cells containing
either the JFH-1 virus or full-length JFH-1 genomic replicons
(pFGR-JFH-1 WT or pFGR-JFH-1 DE/YN). Lysates, generated
by lysing 8610
5 cells in 600 ml of IP buffer (50 mM Tris-HCl,
pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM
PMSF, 1 mM DTT, 1x protease inhibitor cocktail), were
incubated with His-select Nickel affinity gel (Sigma) prior to
binding. Three-hundred micrograms of His-CyPA protein was
preincubated with increasing amounts of cyclosporine A for
30 min at 4uC. The recombinant protein was then mixed with
50 ml of cleared lysate and incubated at 4uC or 1 hour. Freshly
equilibrated resin was then added to each sample and allowed to
Figure 8. The NS5A DY motif confers CsA resistance and
reduced CyPA dependence in a GT1b replicon. (A) The D320E/
Y321N mutations increased CsA resistance level of a Con1 replicon with
or without a NS5B mutation associated with CsA resistance. The
replicon cells were treated with CsA for 4 days and then lysed for
analysis of NS5A expression with western blotting. Data shown
represent two independent experiments. (B) DEYN-containing Con1
replicons can efficiently replicate in CyPA knockdown cells. Colony
formation assays were performed in both control and knockdown cells
with WT and mutant RNA genomes.
doi:10.1371/journal.ppat.1001118.g008
cells selected in 3 mM CsA were cross resistant with a CsA analog that inhibits CyPA but does not bind calcineurin. (E) ‘‘Supertransfection’’ of CsA-
resistant replicon cells with a WT 1b replicon showed that resistance to CsA is conferred by mutations in the replicon RNA rather than in the host cell.
(F) The D320E mutation, engineered into a WT 1a replicon in isolation, conferred resistance to CsA but not to 29CMeA. Error bars represent standard
derivations of three independent experiments. (G) Transient replication of D320E 1a replicon in sh-A161 cells. A GT1a replicon containing a Renilla
luciferase reporter gene was used for this assay. The replication capacities of WT and D320E replicons were measured in both Huh-7.5 sh-Luc and
Huh-7.5 sh-A161 cells.
doi:10.1371/journal.ppat.1001118.g007
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and the supernatant removed. Three washes were performed using
wash buffer (50 mM sodium phosphate, 10 mM imidazole,
250 mM sodium chloride, pH 8.0) followed by elution with wash
buffer containing 250 mM imidazole. The flowthrough and eluted
(CyPA-bound) fractions were then analyzed by SDS-PAGE and
western blotting.
RT-PCR and sequencing. Sequences of primer sets used in RT-
PCR reactions to amplify JFH-1 genome are available upon
request. PCR products were sequenced directly or as cloned
inserts in a pCR2.1-TOPO vector (Invitrogen, CA).
In vitro transcription, electroporation, HCVcc production,
and quantitative RT-PCR
These methods have been described previously [4,42].
Pulse-chase labeling
The metabolic labeling and immunoprecipitation were per-
formed essentially as previously described [5]. Huh-7 Lunet/T7
cells were transfected with subgenomic NS3 to NS5B JFH-1
expression constructs derived from the WT or DEYN mutant or
with the empty vector (pTM1-2). After 22 h, cells were starved for
1 h in methionine/cysteine-free medium and then pulse-labeled
for 1 h with [
35S] methionine/cysteine (150 mCi/ml Express
Protein labeling mix). Cells were lysed immediately (0) or
incubated with nonradioactive medium for 1 or 2 additional
hours (chase). Immunoprecipitation was performed with a
monoclonal NS5A-specific antibody. Samples were processed by
SDS-PAGE (8%), followed by fluorography and autoradiography.
Mutagenesis
Site-directed mutagenesis was carried out with a QuikChange
kit (Stratagene, CA). Sequences of mutagenesis primers for all the
prolines and the DY motif are available upon request. Fragments
containing the mutated NS5A sequence were also cloned into a
pTM NS3-39 plasmid to produce subgenomic NS3 to NS5B JFH-
1 expression constructs containing the corresponding mutations
(pTM NS3-39DEYN JFH-1).
Replicon assays
One microgram of in vitro transcribed WT and mutant RNAs were
electroporated into 4610
6 Huh-7.5 cells stably expressing shRNAs.
For the 1a replicons, replication was measured transiently at 4, 48, 72
and 96 hrs post-electroporation. The 1b replicons were allowed to
form colonies after three weeks of selection and the resulting colonies
were stained with crystal violet. CsA treatment of the stable 1b replicon
cell lines were performed as described previously [9].
Luciferase assays
Luciferase assays was performed according to the manufactur-
er’s instructions for the Dual-Glo Luciferase Assay System from
Promega (Madison, WI) with two exceptions: the Luciferase Assay
System was used for the Genotype 1b supertransfection exper-
iments, and the Renilla Luciferase Assay System was used for the
Genotype 1a D320E mutant. Of note, the J6-JFH-1 reporter virus
carries a Renilla luciferase gene that is not a target of sh-Luc, which
is directed against the firefly luciferase gene.
Core ELISA
HCV core ELISA was performed according to the manufac-
turer’s instructions for the HCV Antigen ELISA kit (Ortho-
Clinical Diagnostics, Japan).
Circular dichroism spectroscopy
Circular dichroism data were collected with a Jasco J-810
spectropolarimeter (Jasco Inc., MD) equipped with Peltier temper-
ature control. The spectra were recorded as averages of 5 scans in
20 mM sodium phosphate, 50 mM NaCl, pH 6.5 buffer at 0.1-nm
resolution and 0.05-cm path length. The wt and DEYN NS5A-D2
protein (6.3 mM) and peptide (50 mM) sample concentrations were
determined by absorbance at 280 nm and the following extinction
coefficients: 14,105 M
21/cm
21 and 15,595 M
21/cm
21 for DEYN
Table 3. Naturally occurring substitutions in HCV NS5A protein sequences.
Position JFH-1 Residue Subst.
a No.
b Accession number
C Total
d Perc.
e
310 P A 1 AJ278830 (1a) 10 (A,S,L) 0.10
315 P A 3 EU155328 (1b)
EF407458 (1b)
AF207757(1b)
10 (A,S,L,T) 0.30
316 D E 7 EF407500 (1b)
AF033364 (1b)
AF033365 (1b)
AJ133098
AJ133099
AF238486 (2b)
AF238481 (2a)
22 (G,S,E,N,Y,A) 0.32
317 Y N 2 DQ491996 (1b)
Y12083 (6a)
9 (N,H,C,D,N) 0.22
317 Y H 1 AF033361 (1b) 9 (N,H,C,D,N) 0.11
319 P A 0 n.a. 1 (L) 0.00
320 P A 0 n.a. 1 (V) 0.00
aSubstitution described in this paper.
bTotal number of sequences with the substitution described in this paper.
cAccession number and genotype of sequences with the substitution described in this paper.
dTotal number of sequences with variation at the this position.
ePercentage of naturally variants that are identical to the substitution described in this paper.
doi:10.1371/journal.ppat.1001118.t003
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21/cm
21 and 6990 M
21/cm
21 for
DEYN and wt peptides, respectively. The NS5A-D2 thermal melt
data were collected at a scan rate of 15uC/h with a 10-min
equilibration time prior to collection of wavelength spectra at 5, 15,
25, 40 and 60uC. All data were acquired in at least triplicate, with
baseline correction and no curve smoothing. The circular dichroism
instrument was calibrated with ammonium (+)-camphor-10-sulfo-
nate by a two-point calibration method described previously [44].
NMR analysis
A synthetic WT peptide corresponding to residues 304-323 of
NS5A (304GFPRALPAWARPDYNPPLVE323) and a peptide
with the double mutations D316E and Y317N were obtained from
NEO BioScience (Cambridge, MA). Purity was determined to be
greater than 98% by high-performance liquid chromatography and
mass spectrometry. Peptide NMR spectra were collected on 1 mM
samples in aqueous buffer at 4uC on a Bruker Avance spectrometer
operating at 700 MHz. Total correlation (TOCSY) spectra were
collected using a clean-DIPSI mixing sequence (100 ms mixing
time) [45] with excitation sculpting solvent suppression [46] as
20486256 complex matrices with spectral width of 7692.3 Hz in
both dimensions. NOESY spectra (400 ms mixing time) were
collected under identical spectrometer conditions using excitation
sculpting solvent suppression [46]. The indirect dimensions were
extended during processing using linear prediction or covariance
techniques [47,48]. The expression and purification of
15N-labeled
human CyPA was carried out as previously described [11] with the
additional purification step of high-performance liquid chromatog-
raphy (Superdex 75, GE Healthcare).
15N-labeled CyPA
(,0.5 mM) was exchanged into NMR buffer (50 mM NaH2PO4/
Na2PO4, pH 6.3, 40 mM NaCl, 2 mM EDTA, and 1 mM DTT),
and peptide was added sequentially to produce the desired final
molar equivalents. 2D
1H,
15N-HSQC NMR spectra [49] were
acquired at 22uC on a Bruker Avance spectrometer operating at
500 MHz
1H frequency. 2D spectra were collected as 10246200
complex matrices with spectral widths of 833.33 Hz and 2500 Hz
in the
1Ha n d
15N dimensions, respectively, from 16 scans per
complex t1 point. Spectra were processed with nmrPipe [50] and
analyzed with NMRView [51].
Supporting Information
Figure S1 Mutations at the DY motif confer reduced CyPA
dependence in the J6-JFH(p7-Rluc2A) background. Mutant RNAs
were transfected into Huh-7.5 sh-Luc and sh-A161 cells by
electroporation. Cells were then collected at the indicated time
points for luciferase assay.
Found at: doi:10.1371/journal.ppat.1001118.s001 (0.75 MB PDF)
Figure S2 The DEYN virus remains sensitive to IFN. Huh-7.5
sh-Luc cells electroporated with either wt or DEYN J6-JFH RNA
were treated with increasing amount of IFN for 3 days before cells
were lysed for luciferase assay. The value of untreated samples
were set to 100%.
Found at: doi:10.1371/journal.ppat.1001118.s002 (0.43 MB PDF)
Figure S3 Mutation of the second DY motif downstream of
D316/Y317 is lethal. (A) A similar DY motif downstream of
D316/Y317. (B) Replication defect of the second DY mutant.
D329EY330N/J6-JFH RNA (DEYN-II) was electroporated into
Huh-7.5 sh-Luc and sh-A161 cells, and luciferase assays were
performed at the indicated time points.
Found at: doi:10.1371/journal.ppat.1001118.s003 (0.47 MB PDF)
Figure S4 Lack of correlation between the phosphorylation
status of NS5A and CyPA-independence. (A) Both p56 and p58 of
NS5A protein bound to CyPA. The binding reactions were
performed as described in Figure 3B with His-tagged CyPA and
the two forms of NS5A were resolved on a 12% SDS-PAGE. (B)
DEYN mutations or CsA treatment does not change the ratio of
p58 versus p56. JFH-1 or DEYN virus infected cells were treated
with 4 mg/ml CsA. Cells were collected 22 hrs after the treatment
and lysate was analyzed on western blot.
Found at: doi:10.1371/journal.ppat.1001118.s004 (0.45 MB PDF)
Figure S5 Chemical shift perturbation plot for binding of wt and
DEYN peptides. Perturbations in amide chemical shift were
calculated as Dd~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dH ðÞ
2z0:167 dN ðÞ
2
q
, where dH (dN) repre-
sents the change in chemical shift in the H (N) dimension in parts
per million. Values for wt peptide are shown as negative values for
ease of viewing. The change in chemical shift indicates a change in
the magnetic environment upon addition of the peptide ligand.
Found at: doi:10.1371/journal.ppat.1001118.s005 (0.50 MB PDF)
Figure S6 DEYN mutations confer CsA resistance to a NS3-
NS5B subgenomic replicon of JFH-1. Stable replicon cells
containing either the WT or the DEYN mutant NS3-NS5B
replicons were treated with increasing amount of CsA for 4 days
before total RNA were extracted for quantitative RT-PCR to
measure both HCV and GAPDH RNA levels.
Found at: doi:10.1371/journal.ppat.1001118.s006 (0.45 MB PDF)
Figure S7 Sh-A161 specifically inhibit expression of CyPA, but
that of other CyP isoforms. Total RNA from Huh-7.5 sh-Luc and
sh-A161 cells were extracted and subjected to semi-quantitative
RT-PCR to analyze the expression level of human CyP isoforms A
through H. Primer sequences for all the CyPs are available upon
request.
Found at: doi:10.1371/journal.ppat.1001118.s007 (0.47 MB PDF)
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